{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:08:03Z","timestamp":1760368083635},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA)"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1054\/plef.2001.0290","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T15:33:28Z","timestamp":1032449608000},"page":"67-72","source":"Crossref","is-referenced-by-count":32,"title":["Activity of a novel dual thromboxane A2receptor antagonist and thromboxane synthase inhibitor (BM-573) on platelet function and isolated smooth muscles"],"prefix":"10.1054","volume":"65","author":[{"given":"S.","family":"Rolin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Dogn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Michaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Delarge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Masereel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1054\/plef.2001.0290_RF1","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1073\/pnas.72.8.2994","article-title":"Thromboxanes: a new group of biological active compounds derived from prostaglandin endoperoxides","volume":"72","author":"Hamberg","year":"1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/plef.2001.0290_RF2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0090-6980(76)90125-8","article-title":"Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes trips of mesenteric and coeliac arteries and inhibits platelet agregation","volume":"12","author":"Bunting","year":"1976","journal-title":"Prostaglandins"},{"key":"10.1054\/plef.2001.0290_RF3","first-page":"293","article-title":"Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2and prostacyclin","volume":"30","author":"Moncada","year":"1979","journal-title":"Pharmacol Rev"},{"key":"10.1054\/plef.2001.0290_RF4","doi-asserted-by":"crossref","unstructured":"Granstr\u00f6m, E. Diczfalusy, U. Hamberg, M. The thromboxanes, Pace-Asciak, C.Granstr\u00f6m, E. Prostaglandins and related Substances, Neuberger, A.van Deenen, L. L. M. New comprehensive Biochemistry, Amsterdam, Elsevier, 1983, 5, 45, 94","DOI":"10.1016\/S0167-7306(08)60534-7"},{"key":"10.1054\/plef.2001.0290_RF5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1073\/pnas.70.3.899","article-title":"Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis","volume":"70","author":"Hamberg","year":"1973","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/plef.2001.0290_RF6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM198103193041201","article-title":"Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease","volume":"304","author":"Hirsch","year":"1981","journal-title":"New Engl J Med"},{"key":"10.1054\/plef.2001.0290_RF7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198610163151602","article-title":"Platelet activation in unstable coronary disease","volume":"315","author":"Fitzgerald","year":"1986","journal-title":"New Engl J Med"},{"key":"10.1054\/plef.2001.0290_RF8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1164\/ajrccm\/141.6.1441","article-title":"Allergen-stimulated release of thromboxane A2and leucotriene E4in humans. Effect of indomethacin","volume":"141","author":"Sladek","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1054\/plef.2001.0290_RF9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0014-2999(86)90105-6","article-title":"Anti-ischemic actions of a new thromboxane receptor antagonist, SQ-29,548, in acute myocardial ischemia","volume":"122","author":"Hock","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0290_RF10","first-page":"832","article-title":"Protective effect of a novel thromboxane synthase inhibitor, CV-4151, on myocardial damage due to coronary occlusion and reperfusion in the hearts of anesthetized dogs","volume":"8","author":"Imamoto","year":"1986","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1054\/plef.2001.0290_RF11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00005344-198701000-00011","article-title":"Cardioprotective actions of specific thromboxane receptor antagonist in acute myocardial ischemia","volume":"9","author":"Brezinsky","year":"1987","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1054\/plef.2001.0290_RF12","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0091-6749(99)70179-X","article-title":"Effect of AA-2414, a thromboxane A2receptor antagonist, on airway inflammation in subjects with asthma","volume":"103","author":"Hoshino","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1054\/plef.2001.0290_RF13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1248\/yakushi1947.119.5_377","article-title":"Thromboxane A2antagonist-discovery of seratrodast","volume":"119","author":"Terao","year":"1999","journal-title":"Yakugaku Zasshi"},{"key":"10.1054\/plef.2001.0290_RF14","first-page":"115497","article-title":"Preparation of [[(3-pyridylmethylene)amino]oxy]alkanoates as blood platelet aggregation inhibitors. Eur Pat Appl EP 221, 601","volume":"107","author":"Freyne","year":"1987","journal-title":"Chem Abstr"},{"key":"10.1054\/plef.2001.0290_RF15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0038-1646523","article-title":"R68070: Thromboxane A2synthase inhibition and thromboxane A2\/prostaglandine endoperoxide receptor blockade combined in one molecule. I. Biochemical profile in vitro","volume":"61","author":"De Clerck","year":"1989","journal-title":"Thromb Haemostasis"},{"key":"10.1054\/plef.2001.0290_RF16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1021\/jm00027a004","article-title":"6,6-disubstituted hex-5-enoic acid derivatives as combined thromboxane A2receptor antagonists and synthase inhibitors","volume":"37","author":"Soyka","year":"1994","journal-title":"J Med Chem"},{"key":"10.1054\/plef.2001.0290_RF17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003495-199141010-00008","article-title":"Torasemide. A review of its pharmacological and therapeutic potential","volume":"41","author":"Friedel","year":"1991","journal-title":"Drugs"},{"key":"10.1054\/plef.2001.0290_RF18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0952-3278(92)90227-A","article-title":"A novel loop diuretic, torasemide, inhibits thromboxane A2-induced contraction in isolated canine coronary artery","volume":"45","author":"Uchida","year":"1992","journal-title":"Prostagl Leukot and Ess Fat Ac"},{"key":"10.1054\/plef.2001.0290_RF19","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1211\/0022357991772998","article-title":"Thromboxane A2Receptor antagonism in Man and Rat by a Sulphonylcyanoguanidine (BM-144) and a Sulphonylurea (BM-500)","volume":"51","author":"Masereel","year":"1999","journal-title":"J Pharm Pharmacol"},{"key":"10.1054\/plef.2001.0290_RF20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1211\/0022357011775992","article-title":"Design, synthesis and biological evaluation of a sulfonylcyanoguanidine as thromboxane A2receptor antagonist and thromboxane synthase inhibitor","volume":"53","author":"Dogn\u00e9","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"10.1054\/plef.2001.0290_RF21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1054\/plef.2000.0160","article-title":"Effects of a novel non-carboxylic thromboxane A2receptor antagonist (BM-531) derived from torasemide on platelet function","volume":"62","author":"Dogn\u00e9","year":"2000","journal-title":"Prostagl Leukot and Ess Fat Ac"},{"key":"10.1054\/plef.2001.0290_RF22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0223-5234(94)90145-7","article-title":"Synthesis and pharmacology of pyrid-3-yl sulfonylureas and sulfonylthioureas as inhibitors of the astrocytic Na+2Cl\u2212K+co-transporter","volume":"29","author":"Masereel","year":"1994","journal-title":"Eur J Med Chem"},{"key":"10.1054\/plef.2001.0290_RF23","first-page":"689","article-title":"Use of infrared spectroscopy in monitoring a new method for the preparation of sulotroban, an antithrombotic drug","volume":"319","author":"Nuhrich","year":"1996","journal-title":"J Chem Educ"},{"key":"10.1054\/plef.2001.0290_RF24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1113\/jphysiol.1963.sp007185","article-title":"The aggregation of blood platelet","volume":"168","author":"Born","year":"1963","journal-title":"J Physiol"},{"key":"10.1054\/plef.2001.0290_RF25","first-page":"125","article-title":"Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives","volume":"5","author":"Harris","year":"1979","journal-title":"J Cyclic Nucleotide Res"},{"key":"10.1054\/plef.2001.0290_RF26","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1021\/ac00284a003","article-title":"Enzyme immunoassays of eicosanoids using acetylcholine esterase as label an alternative to radioimmunoassay","volume":"57","author":"Pradelles","year":"1985","journal-title":"Anal Chem"},{"key":"10.1054\/plef.2001.0290_RF27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0223-5234(96)88244-4","article-title":"Synthesis and pharmacology of pyrid-3-yl sulfonylcyanoguanidines as diuretics","volume":"30","author":"Masereel","year":"1995","journal-title":"Eur Med Chem"},{"key":"10.1054\/plef.2001.0290_RF28","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(84)92328-6","article-title":"BM-13177, a selective blocker of platelet and vessel wall thromboxane receptors, is active in man","volume":"5","author":"Gresele","year":"1984","journal-title":"Lancet"},{"key":"10.1054\/plef.2001.0290_RF29","first-page":"435","article-title":"Pharmacological actions of SQ-29, 548, a novel selective thromboxane antagonist","volume":"234","author":"Ogletree","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1054\/plef.2001.0290_RF30","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1476-5381.1981.tb16814.x","article-title":"Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2and thromboxane A2on some isolated smooth muscle preparations","volume":"73","author":"Coleman","year":"1981","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0290_RF31","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1021\/jm00158a024","article-title":"Thromboxane A2synthase inhibitors. 5-(3-Pyridylmethyl) benzofuran-2-carboxylic acids","volume":"29","author":"Johnson","year":"1986","journal-title":"J Med Chem"},{"key":"10.1054\/plef.2001.0290_RF32","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1021\/jm00059a005","article-title":"Modeling of human thromboxane A2receptor and analysis of the receptor\u2013ligand interaction","volume":"36","author":"Yamamoto","year":"1993","journal-title":"J Med Chem"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095232780190290X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095232780190290X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T22:14:33Z","timestamp":1581027273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095232780190290X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["S095232780190290X"],"URL":"https:\/\/doi.org\/10.1054\/plef.2001.0290","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}